Name: 43rd Annual Neurorehabilitation Conference
Start: 12/11/2022 05:00 AM +00:00
End: 12/11/2022 11:00 PM +00:00

Our robotic therapy solutions have been in the making since 2007. We have introduced innovative robotic technology throughout the years and are incredibly proud of the advancements we have contributed to the medical community. The launch of Burt in 2019 is a significant achievement in promoting upper-limb recovery from neurological injuries such as stroke, traumatic brain injury (TBI), spinal cord injury (SBI), Parkinson's, and others.
Barrett&rsquo;s &ldquo;secret&rdquo; is to motivate patients to perform more repetitions (100s per 15-minute session), which represents the gold standard for neural rehabilitation. Burt minimizes the time needed to get the patient into the games within a couple of minutes. Patients quickly forget they are doing therapy once they get into the game environment and try to beat their latest score. Our team of game designers do everything possible to make Barrett&rsquo;s games as addictive as possible, leading to great results, happy patients, and satisfied insurance companies/Medicare.
Burt allows you to guide the patient&rsquo;s therapy without compromising your own physical health by contorting your body to manipulate a heavy person&rsquo;s arm at the end of an exhausting day of therapy.
Barrett's engineers and clinicians work closely with some of the world&rsquo;s top research centers in rehabilitative medicine, such as US #1-ranked Shirley AbilityLab in Chicago and US #3-ranked Spaulding Rehabilitation Network in Boston, as well as leading research centers in Seoul, Nanjing, and Shanghai.

Barrett Medical

Every person deserves the opportunity for a full, healthy life. As champions for health equity*, by 2024, the American Heart Association will advance cardiovascular health for all, including identifying and removing barriers to health care access and quality.
*Addressing the drivers of health disparities, including the social determinants of health, structural racism, and rural health inequities, is the only way to truly achieve equitable health and well-being for all.
Our Mission is to be a relentless force for a world of longer, healthier lives. The American Heart Association has invested in community health, innovative research, and bold initiatives that save and improve lives. We truly measure our success in longer, healthier lives. By leveraging &nbsp;the strengths of our organization and collaborating with others, we can address the greatest needs in the Greater Boston area.&nbsp;

American Stroke Association

Introduction to the conference presented by Dr. Katz

Douglas Katz

Welcome / Overview

<ul>
<li>The learner will be able to describe the possible mechanisms by which the cerebellum normally contributes to sensorimotor function</li>
<li>The learner will be able to describe learning mechanisms that are intact or impaired in people with cerebellar damage. The learning will be able to describe which may be engaged in rehabilitation of people with cerebellar damage</li>
<li>The learner will be able to describe which compensatory and training mechanisms might be useful for helping people with cerebellar ataxia &nbsp;</li>
</ul>

Amy Bastian, PhD, PT

Understanding learning and control of movement after cerebellar damage 

<ul>
<li>Identify Parkinson&rsquo;s Disease symptoms and diagnosis</li>
<li>Identify non-motor symptoms in Parkinson&rsquo;s Disease that interfere with rehabilitation potential</li>
<li>Describe management strategies for non-motor symptoms to improve patient rehabilitation potential</li>
</ul>

Katelyn Bird

Barrier to Rehabilitation: How to Overcome Parkinson s Disease Non-Motor Symptoms

<ul>
<li>Describe the psychosocial role of food and drink in family dynamics</li>
<li>Explain one ethical framework in health care</li>
<li>Identify costs and benefits in consideration of safety with eating, drinking, and swallowing</li>
</ul>

Paula Leslie, PhD, MA, FRCSLT (UK), Reg HCPC (UK), CCC-SLP (USA)

The Ethics in Eating, Drinking, and Swallowing

<ul>
<li>Describe the etiology and pathophysiology of Multiple Sclerosis</li>
<li>Describe the latest management and treatment of Multiple Sclerosis</li>
</ul>

Salvatore Napoli, MD

The Etiology, Management and Treatment of Multiple Sclerosis 

<ul>
<li>Describe how primary prevention reduces recurrent stroke</li>
<li>Describe the latest methods of treatment of acute stroke including thrombectomy and TPA.</li>
</ul>

Steven Feske, MD

Overview of Acute Ischemic Stroke

<ul>
<li>Discuss the definitions and concept of mild traumatic brain injury (mTBI) in the context of TBI of all pathophysiological types and severities</li>
<li>Describe the pathophysiology of mTBI and factors related to recovery, including neuroplasticity</li>
<li>Identify the typical natural history of recovery of mTBI, atypical recovery trajectories, and predictors of recovery, including factors that may prolong post-injury symptoms</li>
<li>Discuss emerging awareness of Chronic Traumatic Encephalopathy (CTE) and Traumatic Encephalopathy Syndrome (TES) as a cause of symptoms after repetitive head injury, with or without mTBI</li>
<li>Discuss management strategies, including differential diagnosis, strategies to optimize recovery and symptom/problem treatments for mTBI</li>
</ul>
&nbsp;

Brigid Dwyer, MD

Mild Traumatic Brain Injury: Typical Recovery and Prolonged Symptoms

<ul>
<li>Describe the most common serious acute neurologic manifestations of COVID-19</li>
<li>Describe the most common neurologic manifestations of post-acute COVID &ndash; both in hospitalized patients and in those who were never hospitalization</li>
<li>Describe the current evidence behind an approach to rehabilitation for neurologic symptoms/illness following COVID-19</li>
</ul>

Anna Cervantes-Arslanian, MD

Acute and Post-Acute Neurologic Complications of COVID-19

<ul>
<li>Describe virtual reality, the role of immersion and presence and gamification in enhancing rehabilitation</li>
<li>Describe the evidence to support use of VR for persons post-stroke and with Parkinson Disease</li>
<li>Differentiate between custom VR and non-custom serious games in the rehab of a person with a brain injury and discuss practical applications of the technology</li>
</ul>

Judith Deutsch

Virtual Reality and Serious Games for Neurorehabilitation

<ul>
<li>Discuss predictors of recovery in the first 3 months after stroke</li>
<li>Discuss predictors of response to rehabilitation in chronic stroke</li>
<li>Describe new treatments for stroke that integrate predictors</li>
</ul>

David Lin

Predictors of Recovery after Stroke

<ul>
<li>Describe the definition of a clinical practice guideline (CPG) and the methodology used to establish the American Physical Therapy Association&rsquo;s (APTA) CPG for Physical Therapist Management of Parkinson Disease (PD)</li>
<li>Identify the 11 recommendations established by the CPG to guide physical therapist management of patients with PD</li>
<li>Apply the APTA clinical practice guidelines to guide effective physical therapist management of a patient with Parkinson disease</li>
</ul>

Cristina Colón-Semenza

Mary Beth Osborne, PT, DPT, NCS

Physical Therapist Management of Parkinson Disease: Putting the Clinical Practice Guidelines into Practice

<ul>
<li>Define Resiliency and related stressors in life and workplace events</li>
<li>Identify stressors that impact an individual and may affect personal health in all domains</li>
<li>Describe the processes of allostasis and Homeostasis to return to a sense of equilibrium and wellness</li>
</ul>

Donna M. White

The Stress Associated With Caring For Humanity:  Building Resilience and Strategies for Wellness

<ul>
<li>Describe the relevant anatomy and pathophysiology associated with BPPV</li>
<li>Identify important components of the PT exam to help diagnose BPPV and &nbsp;determine &nbsp;which canal(s) is affected</li>
<li>Describe appropriate treatment/repositioning maneuver based on findings</li>
<li>Identify post-maneuver guidelines and follow up</li>
<li>Identify complicating factors for treatment management of BPPV</li>
<li>Discuss follow up recommendations</li>
</ul>

Kathy Joy, PT, MBA

Vestibular Rehabilitation:  Clinical update on examination and treatment management for patients with BPPV

<ul>
<li>Discuss current challenges with the Mayo Clinic Dysarthria Classification System</li>
<li>Explain why DDK task do not assess a speaker&rsquo;s ability to increase articulatory speed</li>
<li>Describe how maximum performance tasks often do not reflect the dysarthria severity based on running speech performance in talkers with dysarthria</li>
<li>Articulate a common rationale for the use of three speech behavioral modification approaches (loud, clear, slow speech cue) to improve speech intelligibility in talkers with dysarthria</li>
<li>Describe how response patterns for clear, loud, and slow speech cues vary with the perceptual outcome measure (i.e., dysarthria severity vs. speech intelligibility) in talkers with Parkinson&rsquo;s disease and multiple sclerosis</li>
<li>Explain how the tongue and the jaw contribute to vowel acoustics and how speech behavioral cues can facilitate change in tongue and jaw contributions to speech acoustics in typical talkers and talkers with dysarthria</li>
</ul>

Antje Mefferd

Kris Tjaden

Articulatory Impairments in Dysarthria

<ul>
<li>Describe the healthcare system need for an interdisciplinary neurorecovery clinic</li>
<li>Describe the overarching design of an interdisciplinary neurorecovery clinic</li>
<li>Discuss occupational, physical, and speech therapy approaches to assessment of patients recovering from acute neurologic illness</li>
<li>Describe psychological and nutrition support for patients recovering from neurologic illness</li>
</ul>

Jessica Ranford

Julie Maggio, PT, DPT, NCS

Ethan Lester

Kristi Emerson, BSN, RN, CNRN

Audrey Cohen

Carmen Kaman Lo, MS, RD, LDN, CNSC

Rationale and Design of an Interdisciplinary Neurorecovery Clinic

<ul>
<li>Describe recent trends in the study of treatments for acquired apraxia of speech (AOS)</li>
<li>Discuss recent, clinically applicable research concerning Sound Production Treatment (SPT)</li>
<li>Describe the treatment steps and ingredients in Combined Aphasia and Apraxia of Speech Treatment (CAAST)</li>
<li>Describe AOS treatment comparison research</li>
</ul>

Julie Wambaugh

Advances in the Treatment of Acquired Apraxia of Speech

<ul>
<li>Explain the urgency of collaboration on post-extubation dysphagia across the continuum of care</li>
<li>List the symptoms of post-extubation dysphagia</li>
<li>Discuss issues that impact the incidence of post-extubation dysphagia (i.e., who is at greatest risk)</li>
<li>List the potential causes of post-extubation dysphagia, along with their underlying structural changes and pathophysiology that you may see on an instrumental examination</li>
<li>Determine the situations that require the team's increased vigilance</li>
<li>Discuss ways to collaborate with nursing and other staff in the ICU and across the continuum of care</li>
</ul>

Karen M Sheffler

Post-Extubation Dysphagia: In This Together!

<ul>
<li>Discuss the etiology, presentation and consequences of undertreated spasticity</li>
<li>Explain the role of therapy in the examination and treatment of Spasticity</li>
<li>Have knowledge in the multidisciplinary nature of spasticity management including preferred treatment combinations for mild, moderate and severe spasticity for focal versus generalized spasticity</li>
<li>Improve knowledge of current evidence related to contemporary spasticity management strategies&nbsp;&nbsp;</li>
</ul>

Lisa Doyle

Spasticity Management-The Role of Physical Therapy and Current Evidence

<ul>
<li>Describe the cognitive deficits most often associated with multiple sclerosis</li>
<li>Describe evidence-based approaches to cognitive rehabilitation in adults with multiple sclerosis</li>
</ul>

Heather Wishart

Cognitive Rehabilitation for Adults with Multiple Sclerosis

<ul>
<li>Describe at least one of the two types of ambiguous loss and provide an example of it</li>
<li>State at least one of Pauline Boss&rsquo;s six therapeutic goals for growing resilience when facing ambiguous loss</li>
<li>Describe one tangible step that people can take in order to grow their resilience when facing an ambiguous loss</li>
</ul>

Pat and Tammy Mcleod

Hit Hard: Letting Go of What Was and Learning to Live Well with What Is

Sample

English

(UTC -04:00) Eastern Time (US & Canada - EDT)

America/New_York

<noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-PQLDKVK"
height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>

Session Catalog

Speakers27 Speakers

Amy Bastian, PhD, PT

Katelyn Bird

Anna Cervantes-Arslanian, MD

Audrey Cohen

Cristina Colón-Semenza

Mary Beth Osborne, PT, DPT, NCS

Judith Deutsch

Lisa Doyle

Brigid Dwyer, MD

Kristi Emerson, BSN, RN, CNRN

Steven Feske, MD

Kathy Joy, PT, MBA

Douglas Katz

Paula Leslie, PhD, MA, FRCSLT (UK), Reg HCPC (UK), CCC-SLP (USA)

Ethan Lester

David Lin

Carmen Kaman Lo, MS, RD, LDN, CNSC

Julie Maggio, PT, DPT, NCS

Pat and Tammy Mcleod

Antje Mefferd

Salvatore Napoli, MD

Jessica Ranford

Karen M Sheffler

Kris Tjaden

Julie Wambaugh

Donna M. White

Heather Wishart

Booth2 Booth

Barrett Medical

American Stroke Association

Session Catalog

Speakers.css-1f6omqm{margin:0;font-size:1.4rem;font-weight:500;line-height:1.5;color:#5d5d5d;font-family:'Poppins',sans-serif;margin-left:0.8rem;}27 Speakers

Amy Bastian, PhD, PT

Katelyn Bird

Anna Cervantes-Arslanian, MD

Audrey Cohen

Cristina Colón-Semenza

Mary Beth Osborne, PT, DPT, NCS

Judith Deutsch

Lisa Doyle

Brigid Dwyer, MD

Kristi Emerson, BSN, RN, CNRN

Steven Feske, MD

Kathy Joy, PT, MBA

Douglas Katz

Paula Leslie, PhD, MA, FRCSLT (UK), Reg HCPC (UK), CCC-SLP (USA)

Ethan Lester

David Lin

Carmen Kaman Lo, MS, RD, LDN, CNSC

Julie Maggio, PT, DPT, NCS

Pat and Tammy Mcleod

Antje Mefferd

Salvatore Napoli, MD

Jessica Ranford

Karen M Sheffler

Kris Tjaden

Julie Wambaugh

Donna M. White

Heather Wishart

Booth.css-7303n9{margin:0;font-size:1.4rem;font-weight:500;line-height:1.5;color:#5d5d5d;font-family:'Poppins',sans-serif;color:#FFFFFF;margin-left:0.8rem;font-weight:400;}2 Booth

Barrett Medical

American Stroke Association

Speakers27 Speakers

Booth2 Booth